nach oben

Pathology & Oncology Research

Erschienen in:

01.10.2014 | Review

WWP2: A Multifunctional Ubiquitin Ligase Gene

verfasst von: Wei Chen, Xiaofei Jiang, Zhuang Luo

Erschienen in: Pathology & Oncology Research | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The ubiquitin-proteasome system plays an important role in various celluar processes. WWP2, a recently identified ubiquitin E3 ligase, has been proved a multifunctional gene by degradation a series of targets via ubiquitin-dependent proteasome system, including PETN, Smads, Oct4, EGR2, TIRF and so. Hereafter, we reviewed the recent research process about the function of WWP2.

Bernassola F, Karin M, Ciechanover A, Melino G (2008) The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14(1):10–21PubMedCrossRef

Chen C, Matesic LE (2007) The Nedd4-like family of E3 ubiquitin ligases and cancer. Cancer Metastasis Rev 26(3–4):587–604PubMedCrossRef

Harvey KF, Kumar S (1999) Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions. Trends Cell Biol 9(5):166–169PubMedCrossRef

Ingham RJ, Gish G, Pawson T (2004) The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene 23(11):1972–1984PubMedCrossRef

Shearwin-Whyatt L, Dalton HE, Foot N, Kumar S (2006) Regulation of functional diversity within the Nedd4 family by accessory and adaptor proteins. BioEssays : news and rev in mol, cell and dev biol 28(6):617–628CrossRef

Kerscher O, Felberbaum R, Hochstrasser M (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159–180PubMedCrossRef

Navon A, Ciechanover A (2009) The 26 S proteasome: from basic mechanisms to drug targeting. J of biol chem 284(49):33713–33718CrossRef

Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S et al (2005) The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123(3):409–421PubMedCrossRef

Alexandru G, Graumann J, Smith GT, Kolawa NJ, Fang R, Deshaies RJ (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134(5):804–816PubMedCrossRefPubMedCentral

10.

Zhong Q, Gao W, Du F, Wang X (2005) Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121(7):1085–1095PubMedCrossRef

11.

Melino G, Gallagher E, Aqeilan RI, Knight R, Peschiaroli A, Rossi M, Scialpi F, Malatesta M, Zocchi L, Browne G et al (2008) Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ 15(7):1103–1112PubMedCrossRef

12.

Kralj M, Tusek-Bozic L, Frkanec L (2008) Biomedical potentials of crown ethers: prospective antitumor agents. ChemMedChem 3(10):1478–1492PubMedCrossRef

13.

Pirozzi G, McConnell SJ, Uveges AJ, Carter JM, Sparks AB, Kay BK, Fowlkes DM (1997) Identification of novel human WW domain-containing proteins by cloning of ligand targets. J of biol chem 272(23):14611–14616CrossRef

14.

Wood JD, Yuan J, Margolis RL, Colomer V, Duan K, Kushi J, Kaminsky Z, Kleiderlein JJ, Sharp AH, Ross CA (1998) Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Mol Cell Neurosci 11(3):149–160PubMedCrossRef

15.

Xu H, Wang W, Li C, Yu H, Yang A, Wang B, Jin Y (2009) WWP2 promotes degradation of transcription factor OCT4 in human embryonic stem cells. Cell Res 19(5):561–573PubMedCrossRef

16.

Soond SM, Chantry A (2011) Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFbeta signalling and EMT. Oncogene 30(21):2451–2462PubMedCrossRefPubMedCentral

17.

Lu PJ, Zhou XZ, Shen M, Lu KP (1999) Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283(5406):1325–1328PubMedCrossRef

18.

Liao B, Jin Y (2010) Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner. Cell Res 20(3):332–344PubMedCrossRef

19.

Wiesner S, Ogunjimi AA, Wang HR, Rotin D, Sicheri F, Wrana JL, Forman-Kay JD (2007) Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 130(4):651–662PubMedCrossRef

20.

Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan ZQ (2008) Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1’s C-terminal tail. Proc Natl Acad Sci U S A 105(34):12230–12235PubMedCrossRefPubMedCentral

21.

Kobashigawa Y, Tomitaka A, Kumeta H, Noda NN, Yamaguchi M, Inagaki F (2011) Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b. Proc Natl Acad Sci U S A 108(51):20579–20584PubMedCrossRefPubMedCentral

22.

Chou YC, Keszei AF, Rohde JR, Tyers M, Sicheri F (2012) Conserved structural mechanisms for autoinhibition in IpaH ubiquitin ligases. J of biol chem 287(1):268–275CrossRef

23.

Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS, Walden H (2011) Autoregulation of Parkin activity through its ubiquitin-like domain. The EMBO j 30(14):2853–2867CrossRef

24.

Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, Chen J (2011) WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol 13(6):728–733PubMedCrossRefPubMedCentral

25.

Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895–902PubMedCrossRef

26.

Al-Hajj M, Clarke MF (2004) Self-renewal and solid tumor stem cells. Oncogene 23(43):7274–7282PubMedCrossRef

27.

Beachy PA, Karhadkar SS, Berman DM (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature 432(7015):324–331PubMedCrossRef

28.

Gidekel S, Pizov G, Bergman Y, Pikarsky E (2003) Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4(5):361–370PubMedCrossRef

29.

Qian YW, Chen Y, Yang W, Fu J, Cao J, Ren YB, Zhu JJ, Su B, Luo T, Zhao XF et al (2012) p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology 142(7):1547–1558PubMedCrossRef

30.

Zhi X, Chen C (2012) WWP1: a versatile ubiquitin E3 ligase in signaling and diseases. Cell and mol life sci : CMLS 69(9):1425–1434PubMedCrossRef

31.

Xu HM, Liao B, Zhang QJ, Wang BB, Li H, Zhong XM, Sheng HZ, Zhao YX, Zhao YM, Jin Y (2004) Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination. J of biol chem 279(22):23495–23503CrossRef

32.

Lu D, Davis MP, Abreu-Goodger C, Wang W, Campos LS, Siede J, Vigorito E, Skarnes WC, Dunham I, Enright AJ et al (2012) MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PLoS ONE 7(8):e40938PubMedCrossRefPubMedCentral

33.

Chen A, Gao B, Zhang J, McEwen T, Ye SQ, Zhang D, Fang D (2009) The HECT-type E3 ubiquitin ligase AIP2 inhibits activation-induced T-cell death by catalyzing EGR2 ubiquitination. Mol Cell Biol 29(19):5348–5356PubMedCrossRefPubMedCentral

34.

Yang Y, Liao B, Wang S, Yan B, Jin Y, Shu HB, Wang YY (2013) E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation. Proceedings of the National Academy of Sciences of the United States of America

35.

McDonald FJ, Western AH, McNeil JD, Thomas BC, Olson DR, Snyder PM (2002) Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na(+) channel. Am j of physiol Renal physiol 283(3):F431–F436

36.

Foot NJ, Dalton HE, Shearwin-Whyatt LM, Dorstyn L, Tan SS, Yang B, Kumar S (2008) Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood 112(10):4268–4275PubMedCrossRef

37.

Li H, Zhang Z, Wang B, Zhang J, Zhao Y, Jin Y (2007) Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells. Mol Cell Biol 27(15):5296–5305PubMedCrossRefPubMedCentral

38.

Marcucci R, Brindle J, Paro S, Casadio A, Hempel S, Morrice N, Bisso A, Keegan LP, Del Sal G, O’Connell MA (2011) Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects. The EMBO j 30(20):4211–4222CrossRef

Titel: WWP2: A Multifunctional Ubiquitin Ligase Gene
verfasst von: Wei Chen
Xiaofei Jiang
Zhuang Luo
Publikationsdatum: 01.10.2014
Verlag: Springer Netherlands
Erschienen in: Pathology & Oncology Research / Ausgabe 4/2014
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-014-9838-y

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

WWP2: A Multifunctional Ubiquitin Ligase Gene

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Screening of Critical Genes in Lung Adenocarcinoma via Network Analysis of Gene Expression Profile

Expression of Eph A4, Eph B2 and Eph B4 Receptors in AML

Amelioration of Colorectal Cancer Using Negative Lipidoid Nanoparticles to Encapsulate siRNA Against APRIL by Enema Delivery Mode

Molecular Heterogeneity of Glioblastoma and its Clinical Relevance

Setting Up a Probe Based, Closed Tube Real-Time PCR Assay for Focused Detection of Variable Sequence Alterations

Psychological Changes in Melanoma Patients During Ipilimumab Treatment Compared to Low-Dose Interferon Alpha Therapy—A Follow-Up Study of First Experiences

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie